Annals of Oncology Advance Access originally published online on August 12, 2005
Annals of Oncology 2006 17(1):173; doi:10.1093/annonc/mdj003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
letter to the editor |
Troponins in prediction of cardiotoxic effects
| The first 10% of the full text of this article appears below. |
We read the work by Kilickap et al. [1
] with great interest. These authors affirm that troponin T (cTnT) could be useful for the early detection of anthracycline-related cardiotoxicity. However, the role of cardiac troponins as indicators of early cardiotoxicity and as predictors of myocardial dysfunction has already
Cardiology Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
* E-mail: daniela.cardinale@ieo.it
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Kilickap, I. Barista, and K. Aytemir Reply to "Troponins in prediction of cardiotoxic effects", by D. Cardinale et al. Ann. Onc., January 1, 2006; 17(1): 173 - 174. [Full Text] [PDF] |
||||
